LINC02513: A Potential Drug Target and Biomarker for various Diseases

Target Name: LINC02513

NCBI ID: G105374410

LINC02513

LINC02513: A Potential Drug Target and Biomarker for various Diseases

LINC02513 (LOC105374410) is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer. The gene is located on chromosome 10 and has been shown to be involved in the development and progression of various diseases.

One of the most significant aspects of LINC02513 is its role in cancer development. Studies have shown that LINC02513 is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. Additionally, LINC02513 has been shown to promote the growth and survival of cancer cells, which suggests that it may be a valuable drug target for cancer treatment.

Another potential application of LINC02513 is as a biomarker for disease diagnosis and monitoring. The gene has been shown to be expressed in a variety of tissues and cells, including blood cells, tissue samples, and cancer cells. Additionally, LINC02513 has been shown to be highly stable and resistant to degradation, which suggests that it could be used as a reliable biomarker for disease tracking and monitoring.

Despite the potential benefits of LINC02513 as a drug target and biomarker, much more research is needed to fully understand its role in disease. Studies are needed to determine the exact mechanism by which LINC02513 promotes cancer growth and survival, as well as to identify potential drugs that can target LINC02513 to treat these diseases.

In conclusion, LINC02513 is a gene that has significant potential as a drug target and biomarker for various diseases. Further research is needed to fully understand its role in disease and to identify potential drugs that can target LINC02513 to treat these conditions.

Protein Name: Long Intergenic Non-protein Coding RNA 2513

The "LINC02513 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02513 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets